HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

minamestane

structure given in first source

Also Known As:

4-aminoandrosta-1,4,6-triene-2,17-dione; FCE 24928; FCE-24928

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Androstanes: 11
      - Androstenes: 5
        Androstatrienes
        minamestane: 1

Related Diseases

1.

Neoplasms (Cancer)

01/01/1993 - "and oral administration, FCE 24928 was effective against DMBA-induced mammary tumors in ovariectomized TP-treated rats, a postmenopausal mammary tumor model."
01/01/1993 - "In addition, FCE 24928 given alone (30 mg/kg daily s.c.) to ovariectomized rats did not affect ovariectomy-induced tumor regression. "
01/01/1993 - "Antitumor activity of the aromatase inhibitor FCE 24928 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone."
01/01/1993 - "The antitumor activity of the irreversible aromatase inhibitor FCE 24928 (4-aminoandrosta-1,4,6-triene-3,17-dione) was studied in ovariectomized and testosterone propionate (TP)-treated rats bearing 7,12-dimethylbenzanthracene (DMBA)-induced mammary tumors. "

Related Drugs and Biologics

1.	Aromatase Inhibitors
2.	Testosterone Propionate
3.	9,10-Dimethyl-1,2-benzanthracene
4.	Testosterone (Sustanon)

Related Therapies and Procedures

1.	Oral Administration
2.	Ovariectomy (Oophorectomy)